Home/Filings/4/0001140361-17-045393
4//SEC Filing

SAVAS PAUL G 4

Accession 0001140361-17-045393

CIK 0001641489other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 7:47 PM ET

Size

6.3 KB

Accession

0001140361-17-045393

Insider Transaction Report

Form 4
Period: 2017-12-06
SAVAS PAUL G
Director
Transactions
  • Purchase

    Class A common stock

    2017-12-06$4.55/sh+10,000$45,50081,781 total
  • Purchase

    Class A common stock

    2017-12-07$4.57/sh+5,000$22,85786,781 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $4.23 to $4.79, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $4.52 to $4.60, inclusive

Issuer

vTv Therapeutics Inc.

CIK 0001641489

Entity typeother

Related Parties

1
  • filerCIK 0001275756

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 7:47 PM ET
Size
6.3 KB